Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.

Cell Death Differ 2017 05 24;24(5):889-902. Epub 2017 Mar 24.

Liver Research Unit, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.

Hepatocellular carcinoma (HCC) is the most common type of liver cancer in humans. The focal adhesion tyrosine kinase (FAK) is often over-expressed in human HCC and FAK inhibition may reduce HCC cell invasiveness. However, the anti-oncogenic effect of FAK knockdown in HCC cells remains to be clarified. We found that FAK depletion in HCC cells reduced in vitro and in vivo tumorigenicity, by inducing G2/M arrest and apoptosis, decreasing anchorage-independent growth, and modulating the expression of several cancer-related genes. Among these genes, we showed that FAK silencing decreased transcription and nuclear localization of enhancer of zeste homolog 2 (EZH2) and its tri-methylation activity on lysine 27 of histone H3 (H3K27me3). Accordingly, FAK, EZH2 and H3K27me3 were concomitantly upregulated in human HCCs compared to non-tumor livers. In vitro experiments demonstrated that FAK affected EZH2 expression and function by modulating, at least in part, p53 and E2F2/3 transcriptional activity. Moreover, FAK silencing downregulated both EZH2 binding and histone H3K27me3 levels at the promoter of its target gene NOTCH2. Finally, we found that pharmacological inhibition of FAK activity resembled these effects although milder. In summary, we demonstrate that FAK depletion reduces HCC cell growth by affecting cancer-promoting genes including the pro-oncogene EZH2. Furthermore, we unveil a novel unprecedented FAK/EZH2 crosstalk in HCC cells, thus identifying a targetable network paving the way for new anticancer therapies.

Download full-text PDF

Source
http://dx.doi.org/10.1038/cdd.2017.34DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423113PMC
May 2017
43 Reads

Publication Analysis

Top Keywords

hcc cells
12
fak
10
enhancer zeste
8
hepatocellular carcinoma
8
zeste homolog
8
fak ezh2
8
hcc cell
8
fak silencing
8
fak depletion
8
histone h3k27me3
8
focal adhesion
8
depletion reduces
8
hcc
7
ezh2
5
livers vitro
4
non-tumor livers
4
compared non-tumor
4
growth modulating
4
upregulated human
4
human hccs
4

References

(Supplied by CrossRef)

HB El-Serag et al.
N Engl J Med 2011

B Njei et al.
Hepatology 2015

JM Llovet et al.
Semin Liver Dis 2005

Q Xu et al.
Sci Rep 2014

C Ozen et al.
Nat Biotechnol 2013

S Li et al.
Cancer Lett 2013

H Okamoto et al.
Hepatology 2003

Z Kan et al.
Genome Res 2013

JT Parsons et al.
J Cell Sci 2003

MD Schaller et al.
J Cell Sci 2010

FJ Sulzmaier et al.
Nat Rev Cancer 2014

Similar Publications